All Substitutes
Loading...
Disclaimer
Did you find this information helpful?
Hosvilda M 50/500mg Tablet
Prescription Required
Salt Composition : Metformin,vildagliptin
Manufacturer : HOSPIMAX HEALTHCARE PVT LTD
Origin of Medicine : India
10 Tablet(s) In A Strip
Introduction to Hosvilda M 50/500mg Tablet
Hosvilda M 50/500mg Tablet contains an active component called Metformin and Vildagliptin. It is used for the management of type 2 diabetes mellitus, which is a chronic condition that affects the way the body processes blood sugar (glucose). This medication can be used to help control high blood sugar levels. It may be used to improve insulin sensitivity in patients who are resistant to the effects of insulin. This medication might be used to manage blood sugar levels in individuals with overweight and obesity-related metabolic disorders.
It should not be used in patients with known hypersensitivity or allergy to Hosvilda M 50/500mg Tablet or any other inactive ingredients in the medication. It should not be used in patients with severe renal impairment (creatinine clearance below 30 mL/min), as the kidneys primarily excrete this medication, and their clearance is reduced in patients with impaired renal function. Patients with a history of ketoacidosis, diabetic ketoacidosis, or lactic acidosis should not use this medication. It is not recommended for patients with severe liver impairment. Conditions such as heart failure, respiratory failure, recent myocardial infarction, and shock, which can lead to tissue hypoxia, are contraindications for the use of this medication.
In patients who will be receiving iodinated contrast agents for radiologic studies, the use of this medication should be temporarily discontinued before or at the time of the procedure and not restarted until at least 48 hours after, provided that renal function has been re-evaluated and found to be stable. Elderly patients may be more susceptible to the side effects of this medication, particularly those related to kidney function. Regular monitoring of kidney function is essential. Hosvilda M 50/500mg Tablet is not recommended for use in children.
Uses of Hosvilda M 50/500mg Tablet
- Management of type 2 diabetes mellitus
- Control of hyperglycemia
- Improvement of insulin sensitivity
- Weight management
Therapeutic Effects of Hosvilda M 50/500mg Tablet
Hosvilda M 50/500mg Tablet works by combining the mechanisms of its two active ingredients, Vildagliptin and Metformin, to manage type 2 diabetes mellitus. Vildagliptin functions by inhibiting the enzyme DPP-4, which increases active incretin hormone levels, stimulating insulin secretion and reducing glucagon release. Metformin reduces hepatic glucose production, enhances peripheral glucose uptake, and improves insulin sensitivity through AMPK activation. This combined action helps regulate blood sugar levels through complementary pathways.
Interaction of Hosvilda M 50/500mg Tablet with other drugs
Inform the doctor about your medicines, including prescription, over-the-counter, nutritional or vitamin supplements, and herbal products. Certain medications may interact with Hosvilda M 50/500mg Tablet, reducing effectiveness by causing undesirable side effects.
More Information about Hosvilda M 50/500mg Tablet
- Store at room temperature, between20°C to 25°C
- Keep away from moisture, heat, and light.
- It should not be frozen.
- Keep away from children and pets.
How to consume Hosvilda M 50/500mg Tablet
Hosvilda M 50/500mg Tablet is administered orally as tablets. The recommended starting dosage and any necessary dose adjustments are determined based on the specific condition being treated and the patient's response to the medication.
Safety Advices for Hosvilda M 50/500mg Tablet
Pregnancy
It is advisable to consult your healthcare provider before taking Hosvilda M 50/500mg Tablet, as it is not recommended during pregnancy
Breast Feeding
It is not safe to use this medication during breastfeeding. It is advised to discontinue either the medication or breastfeeding, depending on the importance of the drug to the mother.
Lungs
Consult your healthcare provider if you have a history of lung conditions before using Hosvilda M 50/500mg Tablet.
Liver
If you have liver disorders, informing your healthcare provider before starting Hosvilda M 50/500mg Tablet is important.
Alcohol
It is advisable to avoid excessive alcohol consumption while taking Hosvilda M 50/500mg Tablet, as it may increase the risk of lactic acidosis. Consult your healthcare provider regarding the consumption of alcohol while on this medication.
Driving
Hosvilda M 50/500mg Tablet may cause dizziness or drowsiness in some patients. If you experience these symptoms, consult your healthcare provider if you experience side effe
Side Effects of Hosvilda M 50/500mg Tablet
Hosvilda M 50/500mg Tablet causes some side effects like all medications, although not everyone will experience them.
Serious
- Lactic acidosis
- Severe allergic reactions
Common
- Gastrointestinal disturbances
- Hypoglycemia
- Headache
- Dizziness
- Weakness or fatigue
- Metallic taste in the mouth
Word of Advice
Regularly check kidney function as Hosvilda M 50/500mg Tablet is eliminated through the kidneys. Be cautious of low blood sugar levels, especially when taking other diabetes medications. Watch for symptoms of lactic acidosis and seek immediate medical help if experienced. Temporarily stop medication before using contrast agents for medical tests. Use with care in patients with liver problems and be mindful of any signs of infection. Inform healthcare providers about the medication before any surgery or medical procedures. Be aware of potential allergic reactions and report any promptly. Monitor for vitamin B12 deficiency during long-term use and consider supplementation if needed. Stay hydrated, especially during illness or in hot weather, to prevent dehydration complications. Consult a healthcare provider for any changes in management during periods of stress, like surgery or infections.
Use with caution during pregnancy and lactation, and discuss potential risks and benefits with a healthcare provider.
FAQs
Q 1. How should I take Hosvilda M 50/500mg Tablet?
It is generally taken orally with a glass of water, usually with meals. Follow your doctor's instructions carefully.
Q 2. Is there a specific diet I should follow while taking Hosvilda M 50/500mg Tablet?
While no specific diet is required while taking Hosvilda M 50/500mg Tablet, following a healthy, balanced diet, as advised by your healthcare provider, can help better manage your blood sugar levels.
Q 3. How long does it take for Hosvilda M 50/500mg Tablet to show its full effect in controlling blood sugar levels?
The time taken for the medication to show its full effect may vary from person to person. Your healthcare provider can give you a better understanding based on your individual response to the Hosvilda M 50/500mg Tablet.
Q 4. What should I do in case of an allergic reaction to Hosvilda M 50/500mg Tablet?
Seek immediate medical attention if you experience any signs of a severe allergic reaction, such as rash, itching, swelling, or difficulty breathing after taking Hosvilda M 50/500mg Tablet.
Q 5. What are the common side effects of Hosvilda M 50/500mg Tablet?
Common side effects of Hosvilda M 50/500mg Tablet may include gastrointestinal disturbances, headache, dizziness, weakness, and a metallic taste in the mouth.
Q 6. What should I do if I miss a Hosvilda M 50/500mg Tablet dose?
If you miss a dose of Hosvilda M 50/500mg Tablet, take it as soon as you remember. However, if it is almost time for your next dose, skip the missed dose and continue with your regular dosing schedule.
Fact Box of Hosvilda M 50/500mg Tablet
Molecule name: Metformin and Vildagliptin | Therapeutic class: Antidiabetic agents
|
Pharmacological class:
| Indications: 1. Management of type 2 diabetes mellitus 2. Control of hyperglycemia 3. Improvement of insulin sensitivity 4. Weight management |
References
- Pharmadox Healthcare Ltd., Electronic Medicines Compendium (EMC), [Revised on August 2023] [Accessed on 22nd Oct 2023], https://www.medicines.org.uk/emc/files/pil.14380.pdf
- Galenicum Health, S.L, [Revised on April 2023] [Accessed on 22nd Oct 2023], https://medicinesauthority.gov.mt/file.ashx?f=0594EAF2C2622B403776FD1C302BFCBAFBF6CB6184EDD15C
- Martha S. Nolte Kennedy, Umesh Masharani, Pancreatic Hormones & Anti-diabetic Drugs, Lange’s Basic & Clinical Pharmacology, 14th Edition, 2018, 747-771.
- KD Tripathi, Insulin, Oral Antidiabetic Drugs and Glucagon, Essentials of Medical Pharmacology, 8th Edition, 2019, 280-305.
Disclaimer
MrMed’s primary intention is to ensure that its consumers get information that is reviewed by experts, accurate and trustworthy. The information and contents of this website are for informational purposes only. They are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of your doctor and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay in seeking it because of something you have read on MrMed. Our mission is to support, not replace, the doctor-patient relationship.
